Suchergebnisse - "Kugener, Luc"

PubPharm (136)

81

Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load : we are not sure

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Jan 10;24(1):12. - PMID 31924246

82

Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure

enthalten in: Critical care | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

83

Acyclovir for ventilator-associated pneumonia refractory to antibiotics and with high viral herpes simplex load: we are not sure

enthalten in: Critical care | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

84

With the current COVID pandemic : should we use single-use flexible bronchoscopes instead of conventional bronchoscopes?

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

85

With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes?

enthalten in: Critical care | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

86

With the current COVID pandemic: should we use single-use flexible bronchoscopes instead of conventional bronchoscopes?

enthalten in: Critical care | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

87

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19 : we are not sure

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Apr 2;24(1):128. - PMID 32241301

88

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure

enthalten in: Critical care | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

89

Therapeutic plasma exchange as a routine therapy in septic shock and as an experimental treatment for COVID-19: we are not sure

enthalten in: Critical care | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

90

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients : is moderate ARDS the best indication for neuromuscular blocking agents

enthalten in: Critical care (London, England) | 2020

von Honore, P. | Mugisha, A. | Kugener, L. | +4

CommentOn: Crit Care. 2020 Feb 17;24(1):54. - PMID 32066488